RECOMBINANT IgG Fc MULTIMERS FOR THE TREATMENT OF NEUROMYELITIS OPTICA

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20210095006A1
SERIAL NO

16772186

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This disclosure provides the use of recombinant IgG Fc multimers for the treatment of neuromyelitis optica (NMO), and methods of treating NMO by administering such multimers.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CSL BEHRING RECOMBINANT FACILITY AGWANKDORFSTRASSE 10 BERN 3041

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
BAZ, MORELLI Adriana Carlton, AU 8 16
SPIRIG, Rolf Bern, CH 7 30
TRADTRANTIP, Lukmanee San Francisco, US 6 13
VERKMAN, Alan San Francisco, US 14 152

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation